UCSF home page About UCSF UCSF Medical Center
UCSF home page | About UCSF | UCSF Medical Center

Skip to TransPortal content

Decrease the text sizeRestore original text sizeIncrease the text size Enlarge Text
Click to increase the text size. Restore Text
Click to restore original text size. Reduce Text
Click to decrease the text size.
Transporter Database banner  
Decrease the text size | Restore text size | Increase the text size
 Text Sizer image
Home About and More Information Transporter Data Index
Search:  
 

Montelukast

Substrate Information
Inhibitor Information
Clinical Drug-drug Interactions

In Vitro Substrates

No substrate information.


Back to top

In Vitro Inhibitors

* denotes drugs that can potentially be used for in vivo (clinical) studies of the designated transporter
Transporter Synonyms Inhibitor IC50 (μM) Ki (μM) Substrate used Cell System Reference
SLCO1B3 OATP1B3, OATP8 Montelukast 15 Amanitin MDCK II-OATP1B3 Letschert, 2006
SLCO1B1 OATP1B1, OATP-C, OATP2, LST-1 Montelukast 10 Bromsulphthalein MDCK II-OATP1B1 Letschert, 2006
SLCO1B3 OATP1B3, OATP8 Montelukast 0.5 Bromsulphthalein MDCK II-OATP1B3 Letschert, 2006
SLCO2B1 OATP2B1, OATP-B Montelukast 1 Bromsulphthalein MDCK II-OATP2B1 Letschert, 2006
SLCO1B1 OATP1B1, OATP-C, OATP2, LST-1 Montelukast 2.04 Cerivastatin HEK-OATP1B1 Tamraz, 2013
SLCO2B1 OATP2B1, OATP-B Montelukast 0.38 Dibromofluorescein HEK293-OATP2B1 Unger, 2020
SLCO1B1 OATP1B1, OATP-C, OATP2, LST-1 Montelukast 1.4 Estrone sulfate HEK-OATP1B1 Tamraz, 2013

Back to top

Clinical Drug-Drug Interactions

No drug-drug interaction information.


Back to top

Contact us | Glossary

Blue banner